Literature DB >> 9042021

New insights into the understanding of asthma.

R J Davies1, J Wang, M M Abdelaziz, M A Calderon, O Khair, J L Devalia, C Rusznak.   

Abstract

The prevalence of asthma is increasing, despite better understanding of its pathogenesis and improved treatments. During the past 10 years, the perception of asthma has shifted from a disease primarily characterized by altered smooth muscle function to one mainly characterized by chronic inflammation. This article reviews the evidence supporting the relationship of inflammation in both the upper and lower airways, focusing on intermittent seasonal disease as well as on the more chronic and severe forms of asthma, including that associated with aspirin intolerance. It also presents evidence to support a pivotal role for the epithelial cell, together with the mast cell and the eosinophil, in initiating and maintaining inflammation in the upper and lower airways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042021     DOI: 10.1378/chest.111.2_supplement.2s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

2.  Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.

Authors:  D M Stafforini; T Numao; A Tsodikov; D Vaitkus; T Fukuda; N Watanabe; N Fueki; T M McIntyre; G A Zimmerman; S Makino; S M Prescott
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

3.  Targeted deletion of Interleukin-3 results in asthma exacerbations.

Authors:  Julia Kölle; Theodor Zimmermann; Alexander Kiefer; Ralf J Rieker; Paraskevi Xepapadaki; Sebastian Zundler; Nikolaos G Papadopoulos; Susetta Finotto
Journal:  iScience       Date:  2022-05-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.